Status:
COMPLETED
Postpartum Pre-exposure Prophylaxis (PrEP) Study to Evaluate an Adherence Promotion Package for Postpartum Women on PrEP
Lead Sponsor:
University of California, Los Angeles
Collaborating Sponsors:
University of Cape Town
Conditions:
HIV-1-infection
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The postpartum PrEP study (PPS) seeks to evaluate how best to improve adherence to PrEP in postpartum women and to evaluate how acceptable it is to offer HIV self tests for the participant and partner...
Detailed Description
Pregnant and breastfeeding women in South Africa are at very high risk of HIV acquisition and vertical HIV transmission during pregnancy, labour and breastfeeding. One-third to half of perinatal HIV t...
Eligibility Criteria
Inclusion
- Currently enrolled in PrEP-PP study and on PrEP
- 18+ years old
- confirmed HIV-negative (confirmed with a 4th generation antigen HIV test)
- confirmed to be postpartum (1-6 months postpartum)
- confirmed to currently have a male partner
- confirmed to have a cell phone that can read and respond to SMS/Whatsapp messages
Exclusion
- Failure to meet all of inclusion criteria
Key Trial Info
Start Date :
November 5 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 18 2021
Estimated Enrollment :
106 Patients enrolled
Trial Details
Trial ID
NCT04897737
Start Date
November 5 2020
End Date
May 18 2021
Last Update
December 8 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Gugulethu Midwife Obstetric Unit
Cape Town, South Africa